VIRMA and cervical carcinoma: YTHDC1 and YTHDF1 have anti-cancer effects in cervical cancer, while ZC3H13, WTAP, HNRNPC, YTHDF3 and VIRMA have tumor-promoting effects in cervical cancer (Fig. 5).